Dr David Blakey

Dr David Blakey is deeply committed to delivering exceptional cancer care to the Mornington Peninsula community, where he has lived and worked for over 20 years. By combining the latest advancements in radiation therapy with a collaborative, multidisciplinary management approach, he ensures his patients receive the highest standard of care, close to home.

Dr David Blakey is a highly experienced radiation oncologist, now working at Icon Cancer Centre at The Bays. David completed his Bachelor of Medicine and Bachelor of Surgery (MBBS) at the University of Melbourne in 1987, and then undertook his specialist training in radiation oncology at Peter Mac, becoming a Fellow of the Royal Australian and New Zealand College of Radiologists (FRANZCR) in 1995. David was appointed to the senior medical staff at Peter Mac that same year, where he remained until 2006, before leaving Peter Mac to establish a new radiation oncology treatment facility at Frankston Private.

David has demonstrated a longstanding commitment to the Mornington Peninsula Shire community, serving as a Visiting Radiation Oncologist at Peninsula Health since 2000, and working at Frankston Private from 2006 to 2024. He actively contributes to the region’s healthcare governance as a current member of The Bays Private Hospital’s Medical Advisory Committee.

Dr Blakey’s dedication to clinical quality and safety is evident through his leadership roles on various advisory committees. He served as Chair of the Safety and Quality Committee for Radiation Oncology Victoria for many years, and has been a member of the Southern Metropolitan Integrated Cancer Service’s (SMICS) Breast Tumour Group, as well as Cancer Council Victoria’s Victorian Chemotherapy Cooperative Group (VCOG) Breast Trials Sub-Committee.

In addition to his clinical and governance responsibilities, David has held several medical education roles, fostering the development of future radiation oncologists. His notable positions include Member of the Education Board and Senior Education Officer for the Royal Australian and New Zealand College of Radiologists (RANZCR), as well as Radiation Oncology Divisional Executive and member of the Education Working Party for the Peter MacCallum Cancer Centre (PMCC). He also served as the inaugural Convenor of the Victorian Radiation Oncology Joint Training Committee.

David accepts referrals for all cancer types and has a special clinical interest in prostate cancer, stereotactic radiation therapy, breast, skin and lung cancers.

Dedicated to providing world-class care, he is proud to continue serving the local community at the Mornington Peninsula’s first dedicated radiation oncology treatment facility, equipped with state-of-the-art treatment technology, and supported by a compassionate and highly skilled care team.

• Harris, N., Tan, M. Y., Blakey, D., et.al. (2023). PSMA-PET Detection of Unusual Metastases in Castrate-Sensitive Prostate Carcinoma. Clinical nuclear medicine, 48(1), 85–89.

• Neville, K., Dreosti, M., Blakey, D., et.al. (2020). Adoption of hypofractionated radiation therapy for early breast cancer in private practice: the GenesisCare experience 2014–2016. Journal of medical imaging and radiation oncology, 64(1), 127–133.

• Drummond, R., Power, A., Blakey, D., et.al. (2005). Changes in practice of breast cancer radiotherapy 1998-2002: an Australasian survey. Australasian radiology, 49(1), 44–52.

• Prince, H. M., Wall, D., Blakey, D., et.al. (2002). CliniMACS CD34-selected cells to support multiple cycles of high-dose therapy. Cytotherapy, 4(2), 147–155.

• Prince, H. M., Bashford, J., Blakey, D., et.al. (2002). Isolex 300i CD34-selected cells to support multiple cycles of high-dose therapy. Cytotherapy, 4(2), 137–145.